Must research benefit human subjects if it is to be permissible?

Must medical experiments with human subjects offer them a ‘favourable risk-benefit ratio’, that is, more expectation of benefit than harm or burden, if they are to be judged as ethically justified? Ethical justification is easier for experiments that do offer net benefit to subjects, but ethical jus...

Full description

Saved in:  
Bibliographic Details
Main Author: Wikler, Daniel (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2017
In: Journal of medical ethics
Year: 2017, Volume: 43, Issue: 2, Pages: 114-117
Online Access: Volltext (JSTOR)
Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000caa a22000002 4500
001 1816155098
003 DE-627
005 20230426115853.0
007 cr uuu---uuuuu
008 220908s2017 xx |||||o 00| ||eng c
024 7 |a 10.1136/medethics-2015-103123  |2 doi 
035 |a (DE-627)1816155098 
035 |a (DE-599)KXP1816155098 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Wikler, Daniel  |e VerfasserIn  |4 aut 
245 1 0 |a Must research benefit human subjects if it is to be permissible? 
264 1 |c 2017 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Must medical experiments with human subjects offer them a ‘favourable risk-benefit ratio’, that is, more expectation of benefit than harm or burden, if they are to be judged as ethically justified? Ethical justification is easier for experiments that do offer net benefit to subjects, but ethical justification is possible also for some experiments that do not. Basic science experiments with healthy volunteers and ‘Phase I’ drug trials that seek to determine tolerable dosage levels are routinely approved by ethical review committees; moreover, guidance they receive from government funding agencies specifically asks them to weigh risks to subjects against benefits to subjects and also benefits to those who may benefit from the knowledge gained in the experiment. If a puzzle remains, it is why there remains any assumption that research ethics requires a ‘favourable risk-benefit ratio’ for the individual research subject. 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 43(2017), 2, Seite 114-117  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:43  |g year:2017  |g number:2  |g pages:114-117 
856 |3 Volltext  |u http://www.jstor.org/stable/44606076  |x JSTOR 
856 |u https://jme.bmj.com/content/medethics/43/2/114.full.pdf  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via page says license)] 
856 4 0 |u https://doi.org/10.1136/medethics-2015-103123  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/43/2/114.abstract  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185609035 
LOK |0 003 DE-627 
LOK |0 004 1816155098 
LOK |0 005 20220908053705 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-03#1CBC1DB05C6B1A820EDB4D1FA84E3BAA92197CAE 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/44606076 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw